Search

everythinglearnresearchcommunity

for

Search:↓

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Tadalafil and Finasteride may help treat aggressive melanoma.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Nanocarriers can improve antioxidant delivery to the skin but face safety and production challenges.

Skin, hair, and nail changes can help detect eating disorders early.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

CEC levels may be a useful marker for predicting prostate cancer progression.

Gene variation affects prostate issues and hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Male pattern baldness does not cause an increased risk of prostate cancer.

Sex hormones affect brain injury differently in males and females.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Retinoic acid affects male and female muscle energy use and function differently.

Omega-6 fats in certain cells boost male hormone production.